- ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
ADAM12 Is a Novel Regulator of Tumor Angiogenesis via STAT3 Signaling.
Molecular cancer research : MCR (2017-08-03)
Roopali Roy, Adelle Dagher, Catherine Butterfield, Marsha A Moses
PMID28765266
ZUSAMMENFASSUNG
ADAM12, (
MATERIALIEN
Produktnummer
Marke
Produktbeschreibung
Sigma-Aldrich
AG 1478, CAS-Nr. 175178-82-2, Calbiochem, A cell-permeable, reversible, ATP-competitive, highly potent and selective inhibitor of epidermal growth factor receptor kinase versus HER2-neu and platelet-derived growth factor receptor kinase.